FID-145

N/A

Report date: 2025/01/26 18:23:37
NME

Base Information

Drug NameFID-145
Drug Alias NameMatrix Metalloproteinase-3 Inhibitor (Fidia Farmaceutici)FID-145 (Fidia Farmaceutici)FID-145
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMatrix metalloproteinase 3 inhibitors
TargetsMatrix metalloproteinase 3
Therapy Area/IndicationsOsteoarthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesFidia Farmaceutici Spa
China Registration ClassN/A

Develop Information

Active CompaniesFidia Farmaceutici Spa
Inactive CompaniesN/A
Active IndicationsOsteoarthritis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A